Clinical Trial Update: Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating inhaled nitric oxide for treatment of sickle cell pain crises has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Sickle Cell
• Sickle Cell Disease

Drugs mentioned

• Nitric oxide inhalation (nitric oxide)

Snippet

Sponsor: Mallinckrodt | Conditions: Anemia, Sickle Cell | Phase 2 | Status: COMPLETED | Results posted: 2010-04-23